betamethasone + ropivacaine

A combination of the synthetic corticosteroid betamethasone and the long-acting local anesthetic ropivacaine. This mixture is utilized for the management of chronic omalgia (shoulder pain), particularly when associated with rotator cuff tendinopathy. Betamethasone provides potent anti-inflammatory effects by acting as a glucocorticoid receptor agonist, reducing the production of inflammatory mediators. Ropivacaine provides analgesia by blocking voltage-gated sodium channels, thereby inhibiting nerve impulse conduction. In the context of clinical research by the Biobizkaia Health Research Institute, this combination serves as a standard-of-care comparator to evaluate the efficacy of biological treatments like platelet-rich plasma (PRP).

Other names

betamethasone and ropivacaine